ACM
ITCI
Atika Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-73,000
| Closed | -$6.1M | – | 98 |
|
|
2024
Q4 | $6.1M | Sell |
73,000
-10,000
| -12% | -$835K | 0.65% | 50 |
|
|
2024
Q3 | $6.07M | Sell |
83,000
-14,500
| -15% | -$1.06M | 0.62% | 48 |
|
|
2024
Q2 | $6.68M | Sell |
97,500
-7,500
| -7% | -$514K | 0.65% | 49 |
|
|
2024
Q1 | $7.27M | Buy |
105,000
+5,000
| +5% | +$346K | 0.72% | 50 |
|
|
2023
Q4 | $7.16M | Buy |
100,000
+14,100
| +16% | +$1.01M | 0.96% | 42 |
|
|
2023
Q3 | $4.47M | Sell |
85,900
-7,000
| -8% | -$365K | 0.59% | 55 |
|
|
2023
Q2 | $5.88M | Buy |
92,900
+39,900
| +75% | +$2.53M | 0.59% | 50 |
|
|
2023
Q1 | $2.87M | Sell |
53,000
-66,000
| -55% | -$3.57M | 0.42% | 57 |
|
|
2022
Q4 | $6.3M | Sell |
119,000
-44,900
| -27% | -$2.38M | 0.91% | 40 |
|
|
2022
Q3 | $7.63M | Sell |
163,900
-85,100
| -34% | -$3.96M | 0.65% | 46 |
|
|
2022
Q2 | $14.2M | Buy |
249,000
+39,000
| +19% | +$2.23M | 1.6% | 21 |
|
|
2022
Q1 | $12.9M | Buy |
+210,000
| New | +$12.9M | 1.08% | 34 |
|